PPARA and metabolic syndrome: Atherogenic dyslipidemia, modulation of nuclear peroxisome proliferator-activated (PPAR), and pro-inflammatory states are also considered the principal components of MetS (3) which is robustly linked to a high risk of developing atherosclerotic cardiovascular disease (CVD) (4).